ONC BeiGene Earnings and EPS analysis

Relative Growth: Rel. Growth: 94

Relative Strength: Rel. Strength: 71

Relative Valuation: Rel. Valuation: 18

Relative Profitability: Rel. Profitability: 96

EPS in 2026 (TTM): $0.45

Last Report Period Date: Jun 30, 2026

As of September 2026, according to BeiGene's latest financial report, the company's current EPS (TTM) is $0.45. In 2025, the company recorded an earnings per share (EPS) of $0.2, which represents an increase compared to its EPS of -$0.47 in 2024. BeiGene's earnings per share for the quarterly report ending on Jun 30, 2026 was $0.16.

ONC earnings history

Historical annual and quarterly earnings per share (EPS) data for BeiGene

EPS (TTM)

$0.45

EPS Growth YoY (Quarterly)

128.6%

EPS (Quarterly)

$0.16

EPS Growth (Quarterly)

The annual EPS in 2025 was $0.2, an increase of 142.6% from -$0.47 in 2024. For the quarter ending Jun 30, 2026, the EPS was $0.16, showing a 128.6% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of June 2026 is $0.45. In 2024, the annual EPS was -$0.47, showing an increase of 27.7% from 2023.

ONC EPS vs price chart

ONC EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

128.6%

EPS growth YoY

142.6%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Over the last 12 months, BeiGene has registered an EPS growth of 128.6% (YoY, quarterly).

ONC Earnings Waterfall

Breakdown of revenue, profit and net income for BeiGene

ONC Earnings vs Peers

What are the earnings of ONC compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
ONC BeiGene Ltd	804.29	142.6%	N/A	N/A
OPK Opko Health Inc	N/A	-275%	N/A	N/A
ORGO Organogenesis Holdings Inc	N/A	1,700%	10.1%	0%

All data is based on quarterly TTM periods, unless otherwise specified.